1. Phosphorylation of MCAD selectively rescuesPINK1deficiencies in behavior and metabolism
- Author
-
Tina M. Cowan, Chung-Han Hsieh, Dominic Winter, Anna I Scott, Meredith M. Course, Carmen Schoor, Amanda M. Papakyrikos, and Xinnan Wang
- Subjects
0301 basic medicine ,Cell Physiology ,PINK1 ,Protein Serine-Threonine Kinases ,Biology ,Acyl-CoA Dehydrogenase ,Animals, Genetically Modified ,Phosphoserine ,03 medical and health sciences ,chemistry.chemical_compound ,Adenosine Triphosphate ,Carnitine ,Animals ,Drosophila Proteins ,Amino Acid Sequence ,Amino Acids ,Phosphorylation ,Molecular Biology ,Peptide sequence ,Fatty acid metabolism ,Kinase ,nutritional and metabolic diseases ,Articles ,Cell Biology ,Metabolism ,Phenotype ,Cell biology ,Drosophila melanogaster ,030104 developmental biology ,chemistry ,Mitochondrial matrix ,Oxidation-Reduction - Abstract
PTEN-induced putative kinase 1 (PINK1) is a mitochondria-targeted kinase whose mutations are a cause of Parkinson’s disease. We set out to better understand PINK1’s effects on mitochondrial proteins in vivo. Using an unbiased phosphoproteomic screen in Drosophila, we found that PINK1 mediates the phosphorylation of MCAD, a mitochondrial matrix protein critical to fatty acid metabolism. By mimicking phosphorylation of this protein in a PINK1 null background, we restored PINK1 null’s climbing, flight, thorax, and wing deficiencies. Owing to MCAD’s role in fatty acid metabolism, we examined the metabolic profile of PINK1 null flies, where we uncovered significant disruptions in both acylcarnitines and amino acids. Some of these disruptions were rescued by phosphorylation of MCAD, consistent with MCAD’s rescue of PINK1 null’s organismal phenotypes. Our work validates and extends the current knowledge of PINK1, identifies a novel function of MCAD, and illuminates the need for and effectiveness of metabolic profiling in models of neurodegenerative disease.
- Published
- 2018
- Full Text
- View/download PDF